Deka Research and Development
Country not established
- Devices
- 17
What Deka Research and Development makes
Deka Research and Development manufactures infusion pumps, subcutaneous delivery systems, and hemodialysis components. Their portfolio includes the Remunity System and Unity Subcutaneous Delivery System for Remodulin, as well as insulin infusion sets like the Sparta Infusion Set. They also produce infusion controllers, hemodialysis systems (e.g., HemoCare Hemodialysis System), and bicarbonate concentrate sets for dialysis. The DEKA Loop and DEKA ACE Pump System are designed for controlled drug delivery, while volumetric infusion controllers support precise fluid administration.
All listed devices fall under FDA Class II regulation and are authorised via the 510(k) pathway. The company’s products are registered with the FDA’s 510(k) clearance system. Deka Research and Development is headquartered in the United States.
Catalogue
Search and filter all 17 devicesFrequently asked questions
How many devices does Deka Research and Development have in the registry?
The registry currently lists 17 devices for Deka Research and Development. Devices recorded under merged duplicate company entries are counted once.
Which registries list Deka Research and Development's devices?
Among its 17 most recently registered devices, Deka Research and Development has devices listed in FDA 510(k) (17 devices).
What risk classes do Deka Research and Development's devices fall under?
Among its 17 most recently registered devices, the classes recorded for Deka Research and Development's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Deka Research and Development in the registry?
The most recently registered devices listed for Deka Research and Development include twiist Automated Insulin Delivery (AID) System, iiSure Infusion Set, Remunity System and Unity Subcutaneous Delivery System for Remodulin.